Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project. (Article, 2007) [WorldCat.org]
skip to content
New WorldCat.org coming soon
Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
Checking...

Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.

Author: Suzanne Robinson Affiliation: Health Economics Facility, Health Services Management Centre, University of Birmingham, 40 Edgbaston Park Road, Birmingham, UK. s.m.robinson@bham.ac.ukChlamydia Screening Studies ClaSS Project GroupTracy RobertsPelham BartonStirling BryanAll authors
Edition/Format: Article Article : English
Publication:Sexually transmitted infections, v83 n4 (200707): 276-81
Other Databases: WorldCatWorldCat
Summary:
Most economic evaluations of chlamydia screening do not include costs incurred by patients. The objective of this study was to estimate both the health service and private costs of patients who participated in proactive chlamydia screening, using mailed home-collected specimens as part of the Chlamydia Screening Studies project. Data were collected on the administrative costs of the screening study, laboratory time  Read more...
More like this
&AllPage.SpinnerRetrieving;

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Document Type: Article
All Authors / Contributors: Suzanne Robinson Affiliation: Health Economics Facility, Health Services Management Centre, University of Birmingham, 40 Edgbaston Park Road, Birmingham, UK. s.m.robinson@bham.ac.uk; Chlamydia Screening Studies ClaSS Project Group; Tracy Roberts; Pelham Barton; Stirling Bryan; John Macleod; Anne McCarthy; Matthias Egger; Emma Sanford; Nicola Low
ISSN:1368-4973
Language Note: English
Unique Identifier: 162104898
Awards:

Abstract:

Most economic evaluations of chlamydia screening do not include costs incurred by patients. The objective of this study was to estimate both the health service and private costs of patients who participated in proactive chlamydia screening, using mailed home-collected specimens as part of the Chlamydia Screening Studies project. Data were collected on the administrative costs of the screening study, laboratory time and motion studies and patient-cost questionnaire surveys were conducted. The cost for each screening invitation and for each accepted offer was estimated. One-way sensitivity analysis was conducted to explore the effects of variations in patient costs and the number of patients accepting the screening offer. The time and costs of processing urine specimens and vulvo-vaginal swabs from women using two nucleic acid amplification tests were similar. The total cost per screening invitation was 20.37 pounds (95% CI 18.94 pounds to 24.83). This included the National Health Service cost per individual screening invitation 13.55 pounds (95% CI 13.15 pounds to 14.33) and average patient costs of 6.82 pounds (95% CI 5.48 pounds to 10.22). Administrative costs accounted for 50% of the overall cost. The cost of proactive chlamydia screening is comparable to those of opportunistic screening. Results from this study, which is the first to collect private patient costs associated with a chlamydia screening programme, could be used to inform future policy recommendations and provide unique primary cost data for economic evaluations.

Reviews

Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.